| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 10/27/2004 | EP1469875A1 Compositions and methods for modulating connexin hemichannels |
| 10/27/2004 | EP1469862A2 Aldosterone receptor antagonist and alpha-adrenergic modulating agent combination therapy for prevention or treatment of cardiovascular conditions |
| 10/27/2004 | EP1469860A2 Anti-cancer combination and use thereof |
| 10/27/2004 | EP1469857A1 Use of pde5 inhibitors in the treatment of scarring and fibrosis |
| 10/27/2004 | EP1469856A2 8-heteroaryl xanthine adenosine a sb 2b /sb receptor antagonists |
| 10/27/2004 | EP1469854A1 Condensed heterocyclic compounds |
| 10/27/2004 | EP1469852A2 Nitric oxide donors for treatment of disease and injury |
| 10/27/2004 | EP1469849A1 Treating stress response with chemokine receptor ccr5 modulators |
| 10/27/2004 | EP1469846A2 Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin |
| 10/27/2004 | EP1469842A2 Bicyclic cb2 cannabinoid receptor ligands |
| 10/27/2004 | EP1469835A2 Stable salts of o-acetylsalicylic acid containing basic amino acids ii |
| 10/27/2004 | EP1469834A1 Multi-stage oral drug controlled-release system |
| 10/27/2004 | EP1469831A1 Pharmaceutical compositions comprising a solid amorphous dispersion of cholesteryl ester transfer protein inhibitors |
| 10/27/2004 | EP1469812A2 Oral insulin therapy |
| 10/27/2004 | EP1373263B1 Heterocyclic compounds for aging-related and diabetic vascular complications |
| 10/27/2004 | EP1272456B1 Hydrazide and alkoxyamide angiogenesis inhibitors |
| 10/27/2004 | EP1246791B1 Aminomethyl-phenyl-cyclohexanone derivatives |
| 10/27/2004 | EP1237578A4 Micro-cluster liquids and methods of making and using them |
| 10/27/2004 | EP1204407B1 Implantable active ingredient depot |
| 10/27/2004 | EP1085858B1 Transdermal therapeutic system for the administration of candesartan |
| 10/27/2004 | EP0970073B1 Process for preparing eprosartan |
| 10/27/2004 | EP0813544B1 Bradykinin antagonist peptides incorporating n-substituted glycines |
| 10/27/2004 | CN1541278A Novel molecular target for neurotoxicity |
| 10/27/2004 | CN1541275A Glycoprotein and process for producing same |
| 10/27/2004 | CN1541271A Methods for large scale prodn. of recombinant DNA-derived tPA or K2S molecules |
| 10/27/2004 | CN1541262A Hops extracts, method for prodn. and use |
| 10/27/2004 | CN1541217A Chemical compounds |
| 10/27/2004 | CN1541216A 8-methoxy-(1,2,4) triazolo (1,5-A) pyridine derivatives and their use as adenosine receptor ligands |
| 10/27/2004 | CN1541211A Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same |
| 10/27/2004 | CN1541208A 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors |
| 10/27/2004 | CN1541107A Growth factor complex |
| 10/27/2004 | CN1541102A Somatostain agonists |
| 10/27/2004 | CN1541092A Method for treating primary insomnia |
| 10/27/2004 | CN1541090A Prepn. of sustained release pharmaceutical compsn. |
| 10/27/2004 | CN1539475A Combination of natural products for curing hyperlipemia, atherosclerosis and relevant disease |
| 10/27/2004 | CN1539474A Drug for treating coronary heart disease, angina and preparation method |
| 10/27/2004 | CN1539471A Prescription for treating cardiovascular disease and processing method |
| 10/27/2004 | CN1539464A Capsule of Chinese traditional medicine for treating thrombus |
| 10/27/2004 | CN1539462A Health product of compound propolis and preparing method |
| 10/27/2004 | CN1539461A Preparation of stabilizing brain for curing apoplexy and migraine and producing method |
| 10/27/2004 | CN1539447A Medicated rehabilitation wine for treating premonitory apoplexy, sequela of apoplexy and obastrcution of qi in chest |
| 10/27/2004 | CN1539444A Compound of Chinese traditional medicine in use for acute stage of apolexy of cerebral cerebral ischemia |
| 10/27/2004 | CN1539439A Medicine for intenerating blood vessel |
| 10/27/2004 | CN1539435A Medicine for treating apoplexy |
| 10/27/2004 | CN1539425A General saponin of stem and leaf of American ginseng in Application of preparing medication for treating mycoarditis |
| 10/27/2004 | CN1539423A Pregnenolone in steroid species and isomeric compound in application of preparing medicaton for treating high blood pressure |
| 10/27/2004 | CN1539415A System with extensible released drug containing extract of hawkthom leaves |
| 10/27/2004 | CN1539407A Solid powder preparaton from liposome of Hypocrellin and producing method |
| 10/27/2004 | CN1172946C Flavone derivatives and preparing process and use thereof |
| 10/27/2004 | CN1172929C Substituted indoles for modulating NFKB activity |
| 10/27/2004 | CN1172926C Astragalus calycosin and its glycoside with the function of resisting myocardial ischemia |
| 10/27/2004 | CN1172908C N-substituted benzy or phenyl aromatic amide copmound and its use |
| 10/27/2004 | CN1172719C Preventives/remedies/progression inhibitors for simplex retinopathy or preproliferating retinopathy |
| 10/27/2004 | CN1172703C Gingko leaf powder for injection and its prepn. |
| 10/27/2004 | CN1172702C Sugar-free erigeron breviscapus granule and its prepn and application |
| 10/27/2004 | CN1172679C Erigreon breviscapus extract controlled releasing tablet and preparation method thereof |
| 10/27/2004 | CN1172677C Application of astragalin A in preparing medicinal composition |
| 10/27/2004 | CN1172673C Use of staurosporine derivatives for treating ocular neovascular diseases |
| 10/27/2004 | CN1172671C Medicial composition for oral administration |
| 10/27/2004 | CN1172665C Combined medicinal preparation of sodium/hydrogen exchange-pump inhibitor and medicine for treatment of angiocardiopathy |
| 10/26/2004 | US6809204 Processes for the preparation of substituted isoxazoles and 2-isoxazolines |
| 10/26/2004 | US6809175 Cadherin derived growth factor and its use |
| 10/26/2004 | US6809119 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases |
| 10/26/2004 | US6809114 4-aminobenzopyran derivatives |
| 10/26/2004 | US6809113 For therapy of arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease, crohn's disease, multiple sclerosis, nephritis, pancreatitis, pulmonary fibrosis, psoriasis, restenosis transplant rejection |
| 10/26/2004 | US6809112 Administering a sexually therapeutically effective amount of a compound having the formula like (5r)-5-(methylamino)-5,6-dihydro-4h-imidazo(4,5,1-ij)quinoline-2(1h)-thione |
| 10/26/2004 | US6809102 For therapy of proliferative diseases, such as cancer; to interrupt mitosis |
| 10/26/2004 | US6809100 Hydroxamic acid derivatives |
| 10/26/2004 | US6809098 Compounds |
| 10/26/2004 | US6809097 Antiangiogenic and/or vascular permeability |
| 10/26/2004 | US6809094 N-fused hetercyclo-1,4- or -1,5- diazabicyclo derivatives; nicotinic receptor agonists; central nervous system (cns) |
| 10/26/2004 | US6809092 1,3,4,5-tetrahydro-2h-2-benzazepin-2-yl derivatives; cysteine protease inhibitors |
| 10/26/2004 | US6809090 Nitrogen monoxide synthase and/or lipidic peroxidation inhibitors |
| 10/26/2004 | US6809089 Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators |
| 10/26/2004 | US6809077 A cyclic polypeptides; immunosuppressive anti-inflammatory activity, inhibiting antigen-induced inflammatory cell infiltration |
| 10/26/2004 | US6808739 Drying method for selectively removing volatile components from wet coatings |
| 10/26/2004 | US6808710 Contacting cell expressing pd-1 with binding agent; genetic transduction of negative signal |
| 10/26/2004 | US6808706 Method for keeping the quality of aqueous parenteral solution of thrombomodulin in storage and distribution |
| 10/26/2004 | CA2294247C Antioxidant enhancement of therapy for hyperproliferative conditions |
| 10/26/2004 | CA2266759C 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase |
| 10/26/2004 | CA2127214C New use of beta-naphtoquinone derivatives and of their salts for the production of a medicament which accelerate the growth of endothelial cells to inhibit no synthtases |
| 10/21/2004 | WO2004090541A1 METHOD OF SCREENING DRUG WITH THE USE OF 67 kDa LAMININ RECEPTOR AND DRUG OBTAINED THEREBY |
| 10/21/2004 | WO2004090157A1 The use of pde4d in the screening for medicaments against atherosclerosis |
| 10/21/2004 | WO2004089990A1 New monoclonal antibody capable of binding integrin alpha 10 beta 1 |
| 10/21/2004 | WO2004089964A1 Lipid-regulating agent and use thereof |
| 10/21/2004 | WO2004089953A1 Purin-6-one-derivatives |
| 10/21/2004 | WO2004089937A1 7-membered heterocyclic derivative |
| 10/21/2004 | WO2004089933A1 Novel crystal of fluorobenzamide derivative |
| 10/21/2004 | WO2004089915A1 Piperazine derivative renin inhibitors |
| 10/21/2004 | WO2004089903A1 Piperidine derivatives as renin inhibitors for the treatment of hypertension |
| 10/21/2004 | WO2004089895A1 Process for the preparation of amorphous calcium salt of atorvastatin |
| 10/21/2004 | WO2004089417A1 Drug-enclosing multilayer structure particulate and process for producing the same |
| 10/21/2004 | WO2004089412A1 Specific nad(p)h oxidase inhibitor |
| 10/21/2004 | WO2004089401A1 Remedy for ischemia |
| 10/21/2004 | WO2004089400A1 Remedy for cardiomyopathy |
| 10/21/2004 | WO2004089399A1 Novel uses of rfrp and ot7t022 |
| 10/21/2004 | WO2004089390A2 Use of quinquina for the preparation of a medicament stimulating angiogenesis |
| 10/21/2004 | WO2004089381A1 Prostaglandin compositions and their use for the treatment of vasospasm |
| 10/21/2004 | WO2004089377A1 Calcium channel blockers comprising two benzhydril moieties |
| 10/21/2004 | WO2004089358A1 Sclerosing solution |